ArticleVirology journal2025
A retrospective study on HIV virological recovery patterns and factors associated with HIV viral treatment using highly active antiretroviral therapy (HAART) in public health facilities in tigray, Northern Ethiopia.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Advancements in development of novel class of HIV protease inhibitors.Annals of medicine · 2026Review
- Preclinical Toxicological evaluation of the HIV entry inhibitor peptide 2P23 as a candidate rectovaginal microbicide.Scientific reports · 2026Article
- Pre-conflict prescription patterns and virological effectiveness of combination antiretroviral therapy (cART) in HIV-1 patients in Tigray, Ethiopia.AIDS research and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundViral load monitoring is crucial for identifying treatment failure in HIV/AIDS patients, as low viremia is essential for public health as HIV cannot spread undetectable. This study aimed to assess the sustained virological recovery rate and potential factors affecting HIV patients in Tigray, Northern Ethiopia, receiving combination treatment.
methodsHIV infected individuals receiving highly active antiretroviral therapy (HAART) were the subjects of the retrospective, cross-sectional investigation held from July 2018 to December 2020. Using a standardized checklist, data was taken from the Tigray Health Bureau database and aligned with data from the Tigray Health Research Institute (THRI). SPSS version 25.0 was used to analyze the data. Predictors for persistent virological recovery were identified based on baseline viral load, baseline CD4 count, current and baseline age, loss to follow-ups, adherence, and WHO clinical presentations. The correlations between each factor and the categorical outcome variables were evaluated using Pearson's χ2. To determine the determinants impacting virological recovery, multivariate logistic regression analyses were performed. Significant relationship levels were established at p < 0.05.
results7689 HIV infected individuals with a mean age of 43 ± 13 years were recruited on HAART with a female predominance of 64.4% with 95% CI: 58.3-76.3. At enrollment to ART sizable portion of the research participants 43.7%, and 38% were in the productive age ranges of 16-30 and 31-45 years old respectively. The overall virological recovery was 90.9% with significant variations among male and female participants AOR; 4.24; 95% CI, 2.97-6.03) and (P < 0.001).
conclusionMale participants showed less recovery, with high baseline CD4 count, long therapy stays, and suppressed viral load being key predictors. The virological recovery (90.9%) remains below the global average which is 95%. Regular assessment of treatment response patterns and drug list combinations is crucial for HIV virological recovery to be sustained. Early enrollment in HAART, tailored interventions, baseline viral load monitoring, longitudinal studies, and gene sequencing are crucial for virological recovery and identifying genetic and behavioral factors contributing to treatment resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.